Western Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $276K | Sell |
621
-70
| -10% | -$31.2K | 0.02% | 571 |
|
|
2025
Q1 | $335K | Buy |
+691
| New | +$335K | 0.02% | 499 |
|
|
2024
Q4 | – | Sell |
-1,052
| Closed | -$489K | – | 763 |
|
|
2024
Q3 | $489K | Buy |
+1,052
| New | +$489K | 0.03% | 475 |
|
|
2024
Q1 | – | Sell |
-947
| Closed | -$385K | – | 730 |
|
|
2023
Q4 | $385K | Buy |
947
+43
| +5% | +$17.5K | 0.03% | 477 |
|
|
2023
Q3 | $314K | Sell |
904
-63
| -7% | -$21.9K | 0.03% | 497 |
|
|
2023
Q2 | $340K | Buy |
+967
| New | +$340K | 0.03% | 474 |
|
|
2022
Q4 | – | Sell |
-722
| Closed | -$208K | – | 797 |
|
|
2022
Q3 | $208K | Buy |
+722
| New | +$208K | 0.01% | 738 |
|
|
2022
Q2 | – | Sell |
-989
| Closed | -$257K | – | 860 |
|
|
2022
Q1 | $257K | Buy |
+989
| New | +$257K | 0.01% | 725 |
|